Orthobiologics are substances that orthopaedic surgeons use to help injuries heal more quickly. They are used to improve the healing of broken bones and injured muscles, tendons, and ligaments. These products are made from substances that are naturally found in your body. Orthobiologics provides accelerated healing, faster recovery and reduction in number of hospital visits. Globally rising incidence of arthritis, geriatric population, growing patient awareness, rising incidences of road accidents and sports related injuries are likely to contribute towards the growth of this market in the forecast period.
The global orthobiologics market report provides market size (Revenue USD Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021).
The global orthobiologics market segmentation is based on product types (allograft, bone morphogenetic proteins, demineralized bone matrix, machined bones, stem cell therapy, synthetic bone substitutes, viscosupplementation), and applications (spinal fusion, trauma, reconstructive surgery).
The global orthobiologics market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market and provides analysis of the company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market. The global orthobiologics market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global orthobiologics market and included in this report are DePuy Sythes, Inc., Medtronic, Inc., NuVasive, Inc., Orthofix, Inc., Stryker Corporation., and Wright Medical Technology, Inc.